23 hrs ago
Medtronic peripheral intervention device cost effective as well as clinically superior
In a 1,500-patient post-market study, Medtronic's IN.PACT Admiral drug-coated balloon peripheral artery intervention device outperformed standard percutaneous transluminal angioplasty both clinically and economically. The 12-month clinically-driven target lesion revascularization rate was 2.4% for the IN.PACT Admiral DCB compared to 20.6% for standard PTA.
Mon Sep 15, 2014
LifeScience AlleyA 30th Anniversary Conference to Feature Global Healthcare Leaders
LifeScience Alley has announced the keynote speakers and premier partners for LSA2014, its 30th anniversary conference being held November 19 in Minneapolis, Minnesota. As payors, providers and the health technology industry navigate sweeping changes in the business models and delivery of healthcare, LSA2014 - The Health Technology Leadership Conference - will offer insights and anticipated impacts from some of the world's most respected organizations.
Up & Coming: Marlene Goldenberg
In the year since graduating from law school, Marlene Goldenberg has taken a leading role in a mass tort litigation being handled by her father's Minneapolis law firm. "Marlene has been instrumental in helping our firm lead the Medtronic infuse bone graft litigation in Minnesota and around the country," Goldenberg Law founder Stuart Goldenberg said in nominating his daughter.
Morningstar Assigns AA- Credit Rating to Medtronic
Medtronic has been given an "AA-" credit rating by analysts at Morningstar . The credit rating agency's "AA-" rating suggests that the company is a very-low default risk.
Sun Sep 14, 2014
Paper Clip-Sized Heart Devices Open New Medtronic Market
Schakel, a 46-year-old Indiana dairy farmer, had a stroke in November, just when he thought he was in the best shape of his life. Doctors couldn't identify a reason, so Schakel now wears the tiny monitor, dubbed the Reveal Linq, inserted under the skin of his chest as he goes about his daily life.
Sat Sep 13, 2014
Bill George: Strong female leadership sets Twin Cities apart
About the author Bill George is professor of management practice at Harvard Business School, author of “True North” and former chairman and CEO of Medtronic. What makes the Twin Cities so vibrant and progressive? First, great institutions in business, education, health care, government, the arts and social services.
Fri Sep 12, 2014
Cath Lab Digest
Symetis Receives CE Mark Approval for Transfemoral Transcatheter...
Symetis joins industry leaders Edwards Lifesciences and Medtronic as only companies to offer both transapical and transfemoral options for transcatheter aortic heart valve delivery Lausanne, Switzerland, September 12, 2014 - Symetis SA, a European developer of transcatheter aortic valve implantation systems, announced today the launch of ACURATE neo, its 15 French compatible transfemoral TAVI system. Commercial implantations started early September after Symetis received CE Mark approval for ACURATE neo this summer.
Medtronic Inc. (MDT) Dividend Stock Analysis
Linked here is a detailed quantitative analysis of Medtronic Inc. . Below are some highlights from the above linked analysis: Medtronic Inc. is a global medical device manufacturer that has leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management and other medical markets.
Thu Sep 11, 2014
The Washington Post
Sloan: Another reason Main Street shouldn't trust Wall Street
Whenever Wall Street comes up with a hot new product, Main Street gets stuck with a bill. That happened with the dot-com mania that inflated and then destroyed stock prices, and with the junk mortgages that inflated and then helped tank the economy.
How Will This New Rating Affect Medtronic (MDT) Stock Today?
The analyst firm set a price target of $68 for the medical equipment maker. Medtronic lacks near-term catalysts, according to Sterne Agee analyst Gregory P. Chodaczek.
Customer Interaction Solutions
Medtronic Named One of the World's Leading Companies for Sustainability
MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index for the fourth year in a row.
Wed Sep 10, 2014
First patients implanted in recapturable aortic valve clinical trial
The clinical trial evaluating the safety and efficacy of Medtronic's CoreValve Evolut R System is underway. The primary efficacy endpoints in the 250-patient prospective study are all-cause mortality and disabling stroke at 30 days and the device success rate at 24 hours to seven days.
Medtronic: Benefits Of Covidien Acquisition Not Enough To Make It A Buy
Medtronic Inc. is a global medical device manufacturer has leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management and other medical markets. Although it is exposed to the highly competitive areas of the medical equipment markets, MDT enjoys many competitive advantages including scale , product breadth and financial strength.
Tue Sep 09, 2014
Medtronic Reaches New 12-Month High at $65.91
Medtronic reached a new 52-week high on Tuesday , American Banking and Market News reports. The company traded as high as $65.91 and last traded at $65.69, with a volume of 5,601,876 shares.
VigiLanz Names Patrick Spangler as Chief Financial Officer
VigiLanz, a digital healthcare technology company headquartered in Minneapolis, announced today the appointment of Patrick Spangler as Chief Financial Officer. Mr. Spangler joins VigiLanz with over 35 years of experience in financial management and over 28 years in the health care IT and medical device industries.
Sun Sep 07, 2014
Medtronic Short Interest Up 5.2% in August
Shares of Medtronic were the recipient of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 64,165,550 shares, an increase of 5.2% from the July 31st total of 61,004,729 shares, Analyst Ratings Network.com reports.
Fri Sep 05, 2014
Medtronic's Neutral Rating Reiterated at Zacks
's stock had its "neutral" rating reaffirmed by Zacks in a research report issued on Friday. They currently have a $67.00 target price on the stock.
Thu Sep 04, 2014
Medical Device/Diagnostic Ind.
Preserving a Midwest Medtech Hub
The Minneapolis-St. Paul medical device industry thrives off robust manufacturing suppliers and skilled workers.
Medtronic Introduces Enhanced Enlite Glucose Sensor for People Living With Diabetes in Canada
Medtronic of Canada today announced the Health Canada license of enhanced Enlitea , the latest iteration of the company's Enlite glucose sensor. The enhanced Enlite is a component of continuous glucose monitoring technology and is designed to provide a more consistent and comfortable experience for people using CGM.
Wed Sep 03, 2014
US Stock Futures Climb Ahead Of ADP Report, Fed's Beige Book
US stock futures gained in early pre-market trade, ahead of economic data. Data on motor vehicle sales for August will be released today.